Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1986 Dec 1;135(11):1282–1285.

Clinicopathological study of fulminant hepatitis: coinfection with hepatitis B virus and delta agent.

S Krajden, F Bishai, S N Huang, A Ronald, F Harris, J Kempston, J Anderson, S Keston
PMCID: PMC1491389  PMID: 3536053

Full text

PDF
1282

Images in this article

1283Fig. 1
on p.1283
1284Fig. 2
on p.1284

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Farci P., Smedile A., Lavarini C., Piantino P., Crivelli O., Caporaso N., Toti M., Bonino F., Rizzetto M. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity. Gastroenterology. 1983 Sep;85(3):669–673. [PubMed] [Google Scholar]
  2. Gmelin K., Roggendorf M., Schlipköter U., Theilmann L., Bommer J., Kommerell B., Deinhardt F. Delta infection in a hemodialyzed patient. J Infect Dis. 1985 Feb;151(2):374–374. doi: 10.1093/infdis/151.2.374. [DOI] [PubMed] [Google Scholar]
  3. Govindarajan S., Chin K. P., Redeker A. G., Peters R. L. Fulminant B viral hepatitis: role of delta agent. Gastroenterology. 1984 Jun;86(6):1417–1420. [PubMed] [Google Scholar]
  4. Govindarajan S., de Cock K. M., Peters R. L. Morphologic and immunohistochemical features of fulminant delta hepatitis. Hum Pathol. 1985 Mar;16(3):262–267. doi: 10.1016/s0046-8177(85)80012-5. [DOI] [PubMed] [Google Scholar]
  5. Hadler S. C., De Monzon M., Ponzetto A., Anzola E., Rivero D., Mondolfi A., Bracho A., Francis D. P., Gerber M. A., Thung S. Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med. 1984 Mar;100(3):339–344. doi: 10.7326/0003-4819-100-3-339. [DOI] [PubMed] [Google Scholar]
  6. Hansson B. G., Moestrup T., Widell A., Nordenfelt E. Infection with delta agent in Sweden: introduction of a new hepatitis agent. J Infect Dis. 1982 Oct;146(4):472–478. doi: 10.1093/infdis/146.4.472. [DOI] [PubMed] [Google Scholar]
  7. Henle W., Henle G., Zajac B. A., Pearson G., Waubke R., Scriba M. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science. 1970 Jul 10;169(3941):188–190. doi: 10.1126/science.169.3941.188. [DOI] [PubMed] [Google Scholar]
  8. Huang S. N., Neurath A. R. Immunohistologic demonstration of hepatitis B viral antigens in liver with reference to its significance in liver injury. Lab Invest. 1979 Jan;40(1):1–17. [PubMed] [Google Scholar]
  9. Popper H., Thung S. N., Gerber M. A., Hadler S. C., de Monzon M., Ponzetto A., Anzola E., Rivera D., Mondolfi A., Bracho A. Histologic studies of severe delta agent infection in Venezuelan Indians. Hepatology. 1983 Nov-Dec;3(6):906–912. doi: 10.1002/hep.1840030603. [DOI] [PubMed] [Google Scholar]
  10. Rizzetto M., Canese M. G., Aricò S., Crivelli O., Trepo C., Bonino F., Verme G. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977 Dec;18(12):997–1003. doi: 10.1136/gut.18.12.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Yamada G., Nakane P. K. Hepatitis B core and surface antigens in liver tissue. Light and electron microscopic localization by the peroxidase-labeled antibody method. Lab Invest. 1977 Jun;36(6):649–659. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES